Abstract
The role of serotonin (5-HT) as a mediator of the endogenous pain control system has been investigated over the last 30 years. Here we review a subset of studies that used electrophysiological techniques to study the mechanisms of action as well as the receptors mediating the spinal effects of serotonin. The works herein discussed employed in vivo or in vitro preparations of control or hyperalgesic animals. According to these reports, 5-HT triggers depressant effects on synaptic transmission limiting the release of neurotransmitters from afferent terminals or the responsiveness of NMDA receptors located in dorsal horn neurones. These mechanisms are most likely mediated by 5-HT1 receptors. In contrast, 5-HT2 receptors seem to mediate excitatory effects such as depolarisation, increased excitability, and neurotransmitter release. The role of 5-HT3 receptors is less clear as they could mediate excitatory or inhibitory effects, depending on variables such as concentration of 5-HT or the state (sensitised/unsensitised) of the spinal cord. The consequences of these spinal effects of serotonin are discussed in the context of pain and analgesia.
Keywords: analgesia, dendrites, dorsal horn neurones, Primary afferent depolarisation (PAD), NMDA transmission
Current Topics in Medicinal Chemistry
Title: Serotonergic Modulation of Spinal Sensory Circuits
Volume: 6 Issue: 18
Author(s): Jose A. Lopez-Garcia
Affiliation:
Keywords: analgesia, dendrites, dorsal horn neurones, Primary afferent depolarisation (PAD), NMDA transmission
Abstract: The role of serotonin (5-HT) as a mediator of the endogenous pain control system has been investigated over the last 30 years. Here we review a subset of studies that used electrophysiological techniques to study the mechanisms of action as well as the receptors mediating the spinal effects of serotonin. The works herein discussed employed in vivo or in vitro preparations of control or hyperalgesic animals. According to these reports, 5-HT triggers depressant effects on synaptic transmission limiting the release of neurotransmitters from afferent terminals or the responsiveness of NMDA receptors located in dorsal horn neurones. These mechanisms are most likely mediated by 5-HT1 receptors. In contrast, 5-HT2 receptors seem to mediate excitatory effects such as depolarisation, increased excitability, and neurotransmitter release. The role of 5-HT3 receptors is less clear as they could mediate excitatory or inhibitory effects, depending on variables such as concentration of 5-HT or the state (sensitised/unsensitised) of the spinal cord. The consequences of these spinal effects of serotonin are discussed in the context of pain and analgesia.
Export Options
About this article
Cite this article as:
Lopez-Garcia A. Jose, Serotonergic Modulation of Spinal Sensory Circuits, Current Topics in Medicinal Chemistry 2006; 6 (18) . https://dx.doi.org/10.2174/156802606778522159
DOI https://dx.doi.org/10.2174/156802606778522159 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preclinical and Clinical Studies on Bryostatins, A Class of Marine-Derived Protein Kinase C Modulators: A Mini-Review
Current Topics in Medicinal Chemistry Peptides As Therapeutics with Enhanced Bioactivity
Current Medicinal Chemistry T Cell Replicative Senescence in Human Aging
Current Pharmaceutical Design Software Packages for Quantitative Microarray-Based Gene Expression Analysis
Current Pharmaceutical Biotechnology The In Silico Prediction of Human-Specific Metabolites from Hepatotoxic Drugs
Current Drug Discovery Technologies α7 Nicotinic Receptor Agonists as Potential Therapeutic Drugs for Schizophrenia
Current Medicinal Chemistry - Central Nervous System Agents Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets HspB1 Dynamic Phospho-Oligomeric Structure Dependent Interactome as Cancer Therapeutic Target
Current Molecular Medicine Editorial (Thematic Selection: Mitochondrial Dysfunction & Neurological Disorders)
Current Neuropharmacology Leptinaemia and Antiendothelial Antibodies in Accelerated Atherosclerosis – Is There a Relationship?
Vascular Disease Prevention (Discontinued) Understanding the Potential Role and Delivery Approaches of Nitric Oxide in Chronic Wound Healing Management
Current Pharmaceutical Design Secondary Recurrent Miscarriage - A Unique Entity with Respect to Etiology and Treatment
Current Women`s Health Reviews Physiological Roles of Neuronal Nicotinic Receptors Subtypes: New Insights on the Nicotinic Modulation of Neurotransmitter Release, Synaptic Transmission and Plasticity
Current Topics in Medicinal Chemistry Pathogenesis of and Therapeutic Strategies to Ameliorate the Transthyretin Amyloidoses
Current Pharmaceutical Design Long-Term Exposure to Ambient Hydrocarbons Increases Dementia Risk in People Aged 50 Years and above in Taiwan
Current Alzheimer Research HIV Risks Among Injecting Drug Users in Vietnam: A Review of the Research Evidence
Current HIV Research The Role of Autophagy in the Pathogenesis of Ischemic Stroke
Current Neuropharmacology Current Issues in Tumor Immunology
Current Bioinformatics Neuropharmacology of Cannabinoid System: From Basic Science to Clinical Applications
Current Neuropharmacology Editorial [Hot Topic: Innate Immunity and Autoimmune Disease (Guest Editors: F. Susan Wong and Li Wen)]
Current Molecular Medicine